Trial intelligence / Profile preview

Prevention of post-ESD esophageal stricture by fluticasone inhaler: single-arm pilot study

KCT0008058Phase 2Completed

Sponsor
Asan Medical Center
Start
Mar 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluticasone in esophageal cancer, sponsored by Asan Medical Center. Started Mar 2023; status: completed.

02

Drugs

fluticasone
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on KCT0008058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call